Saeki T - Search Results

1

Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety.

Shimada H, Ueda S, Saeki T, Shigekawa T, Takeuchi H, Hirokawa E, Sugitani I, Sugiyama M, Takahashi T, Matsuura K, Yamane T, Kuji I, Hasebe T, Osaki A. Shimada H, et al. Among authors: saeki t. Jpn J Clin Oncol. 2015 Jul;45(7):642-9. doi: 10.1093/jjco/hyv055. Epub 2015 May 19. Jpn J Clin Oncol. 2015. PMID: 25989989 Clinical Trial.

2

Chemosensitivity tests in colorectal cancer patients.

Yanagawa E, Nishiyama M, Saeki T, Kim R, Jinushi K, Kirihara Y, Takagami S, Niimoto M, Hattori T. Yanagawa E, et al. Among authors: saeki t. Jpn J Surg. 1989 Jul;19(4):432-8. doi: 10.1007/BF02471624. Jpn J Surg. 1989. PMID: 2810957

3

A phase II study of high-dose epirubicin (EPI) plus cyclophosphamide (CPA) with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors: a trial of the Japan Clinical Oncology Group.

Takashima S, Saeki T, Adachi I, Watanabe T, Sasaki Y, Murai H, Tabei T, Ogita M, Sano M, Kanda K, Shimoyama M. Takashima S, et al. Among authors: saeki t. Jpn J Clin Oncol. 1997 Oct;27(5):325-30. doi: 10.1093/jjco/27.5.325. Jpn J Clin Oncol. 1997. PMID: 9390210 Clinical Trial.

4

Clinical effect of irinotecan in advanced and metastatic breast cancer patients previously treated with doxorubicin- and docetaxel-containing regimens.

Shigeoka Y, Itoh K, Igarashi T, Ishizawa K, Saeki T, Fujii H, Minami H, Imoto S, Sasaki Y. Shigeoka Y, et al. Among authors: saeki t. Jpn J Clin Oncol. 2001 Aug;31(8):370-4. doi: 10.1093/jjco/hye082. Jpn J Clin Oncol. 2001. PMID: 11574629

5

[Recent perspectives second-line chemotherapy for breast cancer].

Fujiuchi N, Ohokubo K, Saeki T, Sasaki Y. Fujiuchi N, et al. Among authors: saeki t. Gan To Kagaku Ryoho. 2005 Jan;32(1):11-4. Gan To Kagaku Ryoho. 2005. PMID: 15675574 Review. Japanese.

6

A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors.

Saeki T, Takashima S, Terashima M, Satoh A, Toi M, Osaki A, Toge T, Ohno S, Nomura N, Fukuyama Y, Koizumi W, Taguchi T. Saeki T, et al. Int J Clin Oncol. 2005 Feb;10(1):51-7. doi: 10.1007/s10147-004-0460-y. Int J Clin Oncol. 2005. PMID: 15729602 Clinical Trial.

7

Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes.

Toi M, Saeki T, Aogi K, Sano M, Hatake K, Asaga T, Tokuda Y, Mitsuyama S, Kimura M, Kobayashi T, Tamura M, Tabei T, Shin E, Nishimura R, Ohno S, Takashima S. Toi M, et al. Among authors: saeki t. Jpn J Clin Oncol. 2005 Jun;35(6):310-5. doi: 10.1093/jjco/hyi090. Epub 2005 Jun 1. Jpn J Clin Oncol. 2005. PMID: 15930037 Clinical Trial.

8

[Current status of adjuvant chemotherapy for breast cancer].

Takeuchi H, Okubo K, Fujiuchi N, Saeki T. Takeuchi H, et al. Among authors: saeki t. Gan To Kagaku Ryoho. 2006 Jun;33(6):736-41. Gan To Kagaku Ryoho. 2006. PMID: 16770090 Review. Japanese.

9

[The incidence and management of bone metastasis from breast cancer].

Saeki T, Ookubo K, Takeuchi H, Fujiuchi N. Saeki T, et al. Gan To Kagaku Ryoho. 2006 Aug;33(8):1054-7. Gan To Kagaku Ryoho. 2006. PMID: 16912520 Japanese.

10

Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer.

Saeki T, Nomizu T, Toi M, Ito Y, Noguchi S, Kobayashi T, Asaga T, Minami H, Yamamoto N, Aogi K, Ikeda T, Ohashi Y, Sato W, Tsuruo T. Saeki T, et al. J Clin Oncol. 2007 Feb 1;25(4):411-7. doi: 10.1200/JCO.2006.08.1646. Epub 2006 Dec 18. J Clin Oncol. 2007. PMID: 17179098 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

746 results

Search Page